Aptose Biosciences (APTO) announced that Nasdaq has granted the company’s request for an extension to evidence compliance with all applicable criteria for continued listing on Nasdaq.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APTO:
Questions or Comments about the article? Write to editor@tipranks.com